Chelsea Therapeutics International, Ltd. (CHTP) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 6 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Gold Treasure Gold Treasure 03/19/2014 3 months $6.35 $4.73 -25.51% -25 Active
Comments:
blas.soto blas.soto 03/13/2014 1 day $5.22 $5.95 +13.98% 13 Ended
Comments:
Eigres Eigres 03/11/2014 1 Year $5.44 $4.73 -13.05% -13 Active
Comments: Product in market. Partnership or buy out
Joward Joward 02/22/2014 1 Year $6.04 $4.73 -21.69% -21 Active
Comments:
villanueva villanueva 02/22/2014 1 Year $6.04 $4.73 -21.69% -21 Active
Comments:
markrefuerzo markrefuerzo 02/22/2014 1 Year $6.04 $4.73 -21.69% -21 Active
Comments:
_chandler_ _chandler_ 02/20/2014 3 months $6.16 $4.73 -23.21% -23 Active
Comments:
Lovegreen Lovegreen 01/17/2014 3 months $4.76 $4.76 no change 0 Ended
Comments: This is only the begining of a ramp ... Read the full entry
DavePellizzari DavePellizzari 05/30/2013 1 month $1.86 $2.30 +23.59% 23 Ended
Comments:
InvestorsXpress InvestorsXpress 02/20/2013 1 week $0.77 $3.51 +358.52% 358 Ended
Comments: Stock has been reanimated for a Northera
JOKER66 JOKER66 02/20/2013 3 months $0.77 $1.84 +140.37% 140 Ended
Comments:
Marty Marty 06/27/2012 3 months $1.32 $1.24 -6.06% -6 Ended
Comments: Industry sector growing or poised for growth
Eventus Eventus 05/24/2012 1 Year $1.81 $3.51 +93.92% 93 Ended
Comments: Upcoming procut launch(es) will be succesfull and underrated stock ... Read the full entry
greatkingrat greatkingrat 02/01/2012 3 months $4.50 $1.10 -75.56% -75 Ended
Comments: droxidopa aka northera fda approval very likely,many insider buys
Steelers#1 Steelers#1 03/23/2010 3 months N/A Ended
Comments: Good high risk stock candidate. Biotech with 2 good drugs in the pipeline. Looking for FDA approval for Northera late 2010 or early 2011.

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.